Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy

Cerebrovascular Diseases

Volumn 36, Issue 1, 2013, Pages 33-37

  Gathier, Celine S ^a   Algra, Ale ^a,b   Rinkel, Gabriël J E ^a   Van Der Worp, H Bart ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anticoagulants; Intracerebral haemorrhage; Outcome

Indexed keywords

ACENOCOUMAROL; PHENPROCOUMON; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; THROMBOEMBOLISM; ANTICOAGULATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FATALITY; INCIDENCE; RISK ASSESSMENT; TREATMENT OUTCOME;

ACENOCOUMAROL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PHENPROCOUMON; PLATELET AGGREGATION INHIBITORS; QUESTIONNAIRES; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL ANALYSIS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84880974900     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000351151     Document Type: Article

References (20)

1. Appelboam R, Thomas EO: Warfarin and intracranial haemorrhage. Blood Rev 2009; 23: 1-9.
2. The ESPRIT study group: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367: 1665-1673.
3. Sjoblom L, Hardemark HG, Lindgren A, Norrving B, Fahlen M, Samuelsson M, Stigendal L, Stockelberg D, Taghavi A, Wallrup L, Wallvik J: Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 2001; 32: 2567-2574.
4. Toyoda K, Yasaka M, Nagata K, Nagao T, Gotoh J, Sakamoto T, Uchiyama S, Minematsu K: Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) retrospective study. Cerebrovasc Dis 2009; 27: 151-159.
5. Bailey RD, Hart RG, Benavente O, Pearce LA: Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 2001; 56: 773-777.
6. O'Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, Ikeda D, Greenberg SM: Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000; 342: 240-245.
7. Schulman S: Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: no. Stroke 2011; 42: 3663-3664.
8. Steiner T: Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: yes. Stroke 2011; 42: 3661-3662.
9. Weimar C, Benemann J, Terborg C, Walter U, Weber R, Diener HC: Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study. Cerebrovasc Dis 2011; 32: 283-288.
10. van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J: Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990; 53: 1080-1083.
11. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
12. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A: Classification of cause of death after stroke in clinical research. Stroke 2006; 37: 1521-1524.
13. Claassen DO, Kazemi N, Zubkov AY, Wijdicks EF, Rabinstein AA: Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol 2008; 65: 1313-1318.
14. Majeed A, Kim YK, Roberts RS, Holmstrom M, Schulman S: Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 2010; 41: 2860-2866.
15. Yung D, Kapral MK, Asllani E, Fang J, Lee DS: Reinitiation of anticoagulation after warfarinassociated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Can J Cardiol 2012; 28: 33-39.
16. Morgenstern LB, Hemphill JC III, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, MacDonald RL, Messe SR, Mitchell PH, Selim M, Tamargo RJ: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41: 2108-2129.
17. European Stroke Organisation: European Stroke Organisation (2006) Recommendations for the Diagnosis and Treatment of Intracerebral Haemorrhage. Available from http://www.eso-stroke.org/lectures/EUSI-ICH-Recommendations-US/ player.html.
18. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
19. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L: Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992.
20. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.